Publikationen in Zusammenarbeit mit Forschern von Massachusetts General Hospital (29)

2014

  1. Left ventricular end-diastolic pressure as an independent predictor of outcome during balloon aortic valvuloplasty

    Catheterization and Cardiovascular Interventions, Vol. 83, Núm. 5, pp. 782-788

  2. The echo score revisited: Impact of incorporating commissural morphology and leaflet displacement to the prediction of outcome for patients undergoing percutaneous mitral valvuloplasty

    Circulation, Vol. 129, Núm. 8, pp. 886-895

2013

  1. Effect of elevated pulmonary vascular resistance on outcomes after percutaneous mitral valvuloplasty

    American Journal of Cardiology, Vol. 112, Núm. 4, pp. 580-584

  2. Long-term experience and outcomes with transcatheter closure of patent foramen ovale

    JACC: Cardiovascular Interventions, Vol. 6, Núm. 11, pp. 1176-1183

2011

  1. Difference in outcome among women and men after percutaneous mitral valvuloplasty

    Catheterization and Cardiovascular Interventions, Vol. 77, Núm. 1, pp. 115-120

  2. Intravascular detection of the vulnerable plaque

    Circulation: Cardiovascular Imaging, Vol. 4, Núm. 2, pp. 169-178

2010

  1. Hyperglycemia on admission predicts larger infarct size in patients undergoing percutaneous coronary intervention for acute ST-segment elevation myocardial infarction

    Diabetes Research and Clinical Practice, Vol. 88, Núm. 1, pp. 97-102

  2. Management of residual shunts after initial percutaneous patent foramen ovale closure: A single center experience with immediate and long-term follow-up

    Catheterization and Cardiovascular Interventions, Vol. 76, Núm. 1, pp. 145-150

2009

  1. Anticoagulation with the direct thrombin inhibitor argatroban in patients presenting with acute coronary syndromes

    Catheterization and Cardiovascular Interventions, Vol. 74, Núm. 2, pp. 359-364

  2. Clinical manifestation and current management of patent foramen ovale

    Expert Review of Cardiovascular Therapy, Vol. 7, Núm. 8, pp. 1011-1022

  3. Coronary artery perforations in the contemporary interventional era

    Journal of Interventional Cardiology, Vol. 22, Núm. 4, pp. 350-353

  4. Endovascular therapy for left main compression syndrome: Case report and literature review

    Chest, Vol. 135, Núm. 6, pp. 1648-1650

  5. Heparin-Induced Thrombocytopenia

    Pharmacology in the Catheterization Laboratory (Wiley-Blackwell), pp. 261-269

  6. Impact of Pre- and Postprocedural Mitral Regurgitation on Outcomes After Percutaneous Mitral Valvuloplasty for Mitral Stenosis

    American Journal of Cardiology, Vol. 104, Núm. 8, pp. 1122-1127

  7. Left atrial appendage exclusion using an Amplatzer device

    International Journal of Cardiology, Vol. 134, Núm. 1

  8. Non-invasive assessment of myocardial ischaemia by using low amplitude oscillations of the conventional ECG signals (ECG dispersion mapping) during percutaneous coronary intervention

    Acta Cardiologica, Vol. 64, Núm. 1, pp. 11-15

  9. Predicting Success and Long-Term Outcomes of Percutaneous Mitral Valvuloplasty: A Multifactorial Score

    American Journal of Medicine, Vol. 122, Núm. 6

  10. Retrograde versus antegrade percutaneous aortic balloon valvuloplasty: Immediate, short- and long-term outcome at 2 years

    Catheterization and Cardiovascular Interventions, Vol. 74, Núm. 2, pp. 225-231

  11. ST-elevation myocardial infarction mortality in a major academic center "on-" versus "off-" hours

    Journal of Invasive Cardiology, Vol. 21, Núm. 10, pp. 518-523

2008

  1. Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: A 3-year clinical outcome study. The Diabetes and Drug Eluting stent for LeFT main registry (D-Delft)

    EuroIntervention, Vol. 4, Núm. 1, pp. 77-83